Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Immune Thrombocytopenia (ITP)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05995054
What this trial is testing

A Prospective, One-arm and Open Clinical Study of Obinutuzumab in the Treatment of Immune Thrombocytopenia

Who this might be right for
Immune ThrombocytopeniaTreatment
Institute of Hematology & Blood Diseases Hospital, China 110
Testing effectiveness (Phase 2)Looking for participantsNCT06094881
What this trial is testing

A Prospective, One-arm and Open Clinical Study of Obinutuzumab in the Treatment of Pediatric Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Immune ThrombocytopeniaTreatment
Institute of Hematology & Blood Diseases Hospital, China 60
Large-scale testing (Phase 3)Study completedNCT01520909
What this trial is testing

Study of a New Medication for Childhood Chronic Immune Thrombocytopenia (ITP), a Blood Disorder of Low Platelet Counts That Can Lead to Bruising Easily, Bleeding Gums, and/or Bleeding Inside the Body.

Who this might be right for
Idiopathic Thrombocytopenic Purpura
GlaxoSmithKline 92
Testing effectiveness (Phase 2)Looking for participantsNCT07549698
What this trial is testing

Safety and Preliminary Efficacy of CTX112 in Adult Participants With Relapsed/Refractory Hematologic Autoimmune Disease

Who this might be right for
Warm Autoimmune Hemolytic Anemia (WAIHA)ITP - Immune ThrombocytopeniaWarm Autoimmune Hemolytic Anemia+1 more
CRISPR Therapeutics AG 60
Post-approval studies (Phase 4)Study completedNCT02556814
What this trial is testing

Caffeic Acid Combining High-dose Dexamethasone in Management of ITP

Who this might be right for
Immune Thrombocytopenia
Shandong University 214
Testing effectiveness (Phase 2)Looking for participantsNCT07175493
What this trial is testing

CM336 in Patients With Relapsed or Refractory Autoimmune Cytopenia

Who this might be right for
Autoimmune CytopeniaImmune Thrombocytopenia (ITP)Autoimmune Hemolytic Anemia+1 more
Keymed Biosciences Co.Ltd 158
Post-approval studies (Phase 4)Study completedNCT02760251
What this trial is testing

Immunomodulation With Romiplostim in Young Adults With ITP

Who this might be right for
Immune Thrombocytopenia
University Hospital, Basel, Switzerland 15
Early research (Phase 1)Looking for participantsNCT07206758
What this trial is testing

Phase I Study of SHR-2173 Injection in Patients With Primary Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Guangdong Hengrui Pharmaceutical Co., Ltd 10
Not applicableStudy completedNCT06444477
What this trial is testing

Molecular Analysis of Thrombocytopenia and Cancer (MATAC): Investigating Antigenic Mimicry Between Platelets and Tumor Cells in Patients With Immune Thrombocytopenia (ITP) Associated With Cancer

Who this might be right for
Immune ThrombocytopeniaImmune Thrombocytopenic PurpuraNeoplasms+1 more
University Hospital, Bordeaux 33
Large-scale testing (Phase 3)WithdrawnNCT02137681
What this trial is testing

A Multicentre Investigation of 2 Cycles Rituximab Compared With Standard Regimen in Management of Steroid-Resistant/Relapsed Immune Thrombocytopenia （ITP）

Who this might be right for
Immune Thrombocytopenia
Shandong University
Testing effectiveness (Phase 2)UnknownNCT06686927
What this trial is testing

Study on Glucocorticoid Combined With Gamma Globulin and Ropristine N01 in Treatment of Initial Severe ITP

Who this might be right for
Primary Immune Thrombocytopenia
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 36
Testing effectiveness (Phase 2)UnknownNCT05369364
What this trial is testing

The Combination of Zanubrutinib and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital 150
Large-scale testing (Phase 3)UnknownNCT05328804
What this trial is testing

Herombopag + rhTPO in Severe Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Yin Jie 90
Testing effectiveness (Phase 2)UnknownNCT04588194
What this trial is testing

Romiplostim, Rituximab and Dexamethasone as Frontline Treatment for Immune Thrombocytopenia

Who this might be right for
Immune ThrombocytopeniaThrombotic Thrombocytopenic Purpura
David Gomez Almaguer 12
Testing effectiveness (Phase 2)UnknownNCT03304288
What this trial is testing

The Combination of Low-dose Rituximab and ATRA as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital 168
Not applicableStudy completedNCT03576742
What this trial is testing

Severe Immune Cytopenia Registry Www.Sic-reg.Org

Who this might be right for
Immune ThrombocytopeniaAutoimmune Hemolytic AnemiaEvans Syndrome+1 more
Medical University of Graz 80
Not applicableStudy completedNCT01013181
What this trial is testing

Safety and Efficacy of Romiplostim in Immune Thrombocytopenia (ITP) in the " Real-life " : Result of the French Experience in 72 Adults

Who this might be right for
Thrombopenia
Henri Mondor University Hospital 100
Not applicableLooking for participantsNCT07612319
What this trial is testing

Romiplostim for Oral TPO-RA Resistant ITP

Who this might be right for
Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
The First Affiliated Hospital of Soochow University 60
Large-scale testing (Phase 3)Active Not RecruitingNCT04562766
What this trial is testing

Study to Evaluate Rilzabrutinib in Adults and Adolescents With Persistent or Chronic Immune Thrombocytopenia (ITP)

Who this might be right for
Immune Thrombocytopenia
Principia Biopharma, a Sanofi Company 232
Not applicableUnknownNCT05468866
What this trial is testing

The Expression of Immune Checkpoint CD28 rs1980422-related Single-nucleotide Polymorphisms in the Primary Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Sohag University 100
Next Page